Centers: Medizinische Hochschule Hannover: Klinik für Pneumologie

Discipline

Pneumologie

Leitung

Prof. Dr. T. Welte Germany

Studies

ID Name Disease Status
11514   Chemotherapy and radiation at stage 3 NSCLC (PROCLAIM) small cell lung cancer
 active
ML19747   Erlotinib vs. carboplatin/vinorelbine in elderly patients with advanced NSCLC non small cell lung cancer
 active
PM 0259 CA 304 J1   Vinorelbine+cisplatin+BSC vs. BSC alone in NSCLC non small cell lung cancer
 active
ML21896   Avastin® with pemetrexed +/- carboplatin to treat NSCLC (65plus) non small cell lung cancer
 active
D4200C00057   ZD6474 vs. erlotinib in NSCLC after failure of at least one prior chemotherapy non small cell lung cancer
 closed
D4200C00044   ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures non small cell lung cancer
 closed
5122   Pemetrexed and BSC vs. Placebo and BSC non small cell lung cancer
 closed
D4200C00036   Vandetamid+Pemetrexed vs. Pemetrexed alone in 2nd Line NSCLC patients non small cell lung cancer
 closed
MORAb-009-003   MORAb-009 + pemetrexed + cisplatin in subjects with mesothelioma various closed
1200.32   BIBW 2992 vs. chemotherapy for NSCLC harbouring an EGFR activating mutation non small cell lung cancer
 closed
1200.42   BIBW 2992 + paclitaxel (weekly) vs. chemotherapy following BIBW 2992 monotherapy non small cell lung cancer
 closed
MO19390   Avastin in combination with platinum-based chemotherapy non small cell lung cancer
 closed
10426   ALIMTA in solid tumor patients with stable third-space fluid non small cell lung cancer
 closed
ATTRACT-2   ASA404 + docetaxel for locally advanced or metastatic NSCLC non small cell lung cancer
 closed
ENOXA-NSCLC
KS-2009-026 		non small cell lung cancer
 closed